menu search

Jaguar health shares replay link for march 14, 2022, investor webcast

Click here to access webcast replay Core 2022 development initiatives: Ongoing operation of Company's OnTarget Phase 3 clinical trial of crofelemer fo...

March 14, 2022, 1:15 pm

Numinus wellness says its research lab receives new biosecurity license for expansion

Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) announced that its research lab, Numinus Bioscience, has been approved by the Public Health Agency of Ca...

March 14, 2022, 12:09 pm

Abbvie (abbv) inks deal for neuropsychiatric conditions

AbbVie (ABBV) forges an alliance with Gedeon Richter to develop novel treatments for neuropsychiatric d...

March 14, 2022, 12:02 pm

Neximmune to present at the barclays 2022 global healthcare conference

GAITHERSBURG, Md., March 10, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a ...

March 10, 2022, 4:26 pm

Karyopharm to participate at the barclays global healthcare conference

NEWTON, Mass. , March 9, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering ...

March 9, 2022, 7:00 am

Xencor to present preclinical data from xmab® cytokine programs at the american association for cancer research (aacr) annual meeting 2022

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytoki...

March 8, 2022, 4:31 pm

Voyager, novartis sign deal worth up to $1.7 billion

Voyager Therapeutics Inc.'s VYGR, +6.22% stock gained 16.8% in premarket trading on Tuesday after the gene therapy company said it inked a deal with N...

March 8, 2022, 8:30 am

Diamedica therapeutics to report fourth quarter 2021 financial results and provide a business update march 15, 2022

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...

March 8, 2022, 8:13 am

Ikena oncology to present preclinical findings on ik-930, a novel tead inhibitor at the 2022 american association for cancer research (aacr) annual meeting

BOSTON, March 07, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company navigating new territory in patient-direct...

March 7, 2022, 4:30 pm

Tracon to report fourth quarter and full year 2021 financial results and corporate update on march 15, 2022

SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the develop...

March 4, 2022, 8:05 am

Tracon to report fourth quarter and full year 2021 financial results and corporate update on march 15, 2022

SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the develop...

March 4, 2022, 8:05 am

X4 pharmaceuticals to present at march investor conferences

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of ...

March 3, 2022, 8:00 am

X4 pharmaceuticals to present at march investor conferences

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of ...

March 3, 2022, 8:00 am

X4 pharmaceuticals to present at march investor conferences

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of ...

March 3, 2022, 8:00 am

Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...

March 2, 2022, 8:05 am

Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...

March 2, 2022, 8:05 am

Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...

March 2, 2022, 8:05 am

Vyant bio says it is ‘well-positioned' to discover novel therapeutics to treat neurological diseases

Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts told shareholders that after its merger the company is “well-positioned” to pursue the discovery of ...

March 1, 2022, 12:20 pm

Vyant bio says it is ‘well-positioned' to discover novel therapeutics to treat neurological diseases

Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts told shareholders that after its merger the company is “well-positioned” to pursue the discovery of ...

March 1, 2022, 12:20 pm

Vyant bio says it is ‘well-positioned' to discover novel therapeutics to treat neurological diseases

Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts told shareholders that after its merger the company is “well-positioned” to pursue the discovery of ...

March 1, 2022, 12:20 pm


Search within

Pages Search Results: